PFIZER INC
PFENYSETrading Snapshot
- Day Range
- $28.10 β $28.52
- 52-Week Range
- $23.58 β $29.21
- Volume
- $4.59B
- Avg Volume
- $5.16B
- Shares Outstanding
- 5.70B
- Next Earnings
- Nov 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $62.58B
- Last Q Revenue
- $15.03B
- P/E Ratio
- 37.7
- P/S Ratio
- 2.6x
- EPS (TTM)
- $0.76
- Dividend Yield
- 5.99%
- Dilution (1yr)
- β0.3%
Why Investors Own PFE
- βHigh-growth profile β revenue up +45.2% YoY with expanding US Equity exposure.
- βHealthy economics β 28% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PFIZER INC
PFEAbout PFIZER INC
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
PFIZER INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift PFE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PFIZER INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.